Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEBPB Antikörper (AA 41-270)

CEBPB Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7147080
  • Target Alle CEBPB Antikörper anzeigen
    CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
    Bindungsspezifität
    • 12
    • 7
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 41-270
    Reaktivität
    • 81
    • 43
    • 41
    • 8
    • 7
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    Human
    Wirt
    • 70
    • 16
    • 1
    • 1
    Kaninchen
    Klonalität
    • 64
    • 24
    Polyklonal
    Konjugat
    • 59
    • 7
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    Dieser CEBPB Antikörper ist unkonjugiert
    Applikation
    • 59
    • 31
    • 22
    • 14
    • 14
    • 14
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human CCAAT/enhancer-binding protein beta protein (41-270AA)
    Isotyp
    IgG
    Top Product
    Discover our top product CEBPB Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
    Andere Bezeichnung
    CEBPB (CEBPB Produkte)
    Synonyme
    C/EBPbeta antikoerper, c/ebp-beta antikoerper, crp2 antikoerper, il6dbp antikoerper, lap antikoerper, nf-il6 antikoerper, tcf5 antikoerper, xC/EBPbeta antikoerper, cebpbb antikoerper, cb380 antikoerper, c/ebpb antikoerper, fe11e05 antikoerper, wu:fe11e05 antikoerper, CEBPB antikoerper, LOC100136165 antikoerper, C/EBP-beta antikoerper, CRP2 antikoerper, IL6DBP antikoerper, LAP antikoerper, NF-IL6 antikoerper, TCF5 antikoerper, IL-6DBP antikoerper, LIP antikoerper, NF-M antikoerper, Nfil6 antikoerper, Il6dbp antikoerper, CCAAT/enhancer binding protein beta antikoerper, CCAAT/enhancer binding protein beta L homeolog antikoerper, CCAAT/enhancer binding protein (C/EBP), beta antikoerper, CCAAT/enhancer-binding protein beta antikoerper, cebpb antikoerper, cebpb.L antikoerper, CEBPB antikoerper, LOC100136165 antikoerper, Cebpb antikoerper
    Hintergrund

    Background: Important transcription factor regulating the expression of genes involved in immune and inflammatory responses (PubMed:1741402, PubMed:9374525, PubMed:12048245, PubMed:18647749). Plays also a significant role in adipogenesis, as well as in the gluconeogenic pathway, liver regeneration, and hematopoiesis. The consensus recognition site is 5\'-T[TG]NNGNAA[TG]-3\'. Its functional capacity is governed by protein interactions and post-translational protein modifications. During early embryogenesis, plays essential and redundant functions with CEBPA. Has a promitotic effect on many cell types such as hepatocytes and adipocytes but has an antiproliferative effect on T-cells by repressing MYC expression, facilitating differentiation along the T-helper 2 lineage. Binds to regulatory regions of several acute-phase and cytokines genes and plays a role in the regulation of acute-phase reaction and inflammation. Plays also a role in intracellular bacteria killing (By similarity). During adipogenesis, is rapidly expressed and, after activation by phosphorylation, induces CEBPA and PPARG, which turn on the series of adipocyte genes that give rise to the adipocyte phenotype. The delayed transactivation of the CEBPA and PPARG genes by CEBPB appears necessary to allow mitotic clonal expansion and thereby progression of terminal differentiation (PubMed:20829347). Essential for female reproduction because of a critical role in ovarian follicle development (By similarity). Restricts osteoclastogenesis (By similarity).

    Aliases: AGP/EBP antibody, C EBP beta antibody, C/EBP beta antibody, C/EBP related protein 2 antibody, CCAAT Enhancer Binding Protein beta antibody, CCAAT/enhancer-binding protein beta antibody, CEBPB antibody, CEBPB_HUMAN antibody, CRP2 antibody, IL 6DBP antibody, IL6DBP antibody, Interleukin 6 dependent binding protein antibody, LAP antibody, Liver activator protein antibody, Liver enriched transcriptional activator antibody, NF IL6 antibody, NFIL6 antibody, Nuclear factor NF IL6 antibody, Nuclear factor NF-IL6 antibody, SF B antibody, SFB antibody, Silencer factor B antibody, TCF-5 antibody, TCF5 antibody, Transcription factor 5 antibody

    UniProt
    P17676
    Pathways
    Interferon-gamma Pathway, Autophagie, Brown Fat Cell Differentiation
Sie sind hier: